Goma umdlavuza womlomo wesibeletho

Yabelana ngalokhu okuthunyelwe

Ingabe ukhona umkhawulo weminyaka wokugoma umdlavuza wesibeletho?

Umgomo wokuqala ogunyaziwe we-HPV wokuvimbela umdlavuza womlomo wesibeletho wethulwa ngokusemthethweni emakethe. Ngaphambi kwalokhu, indlela eyinhloko yokuvimbela umdlavuza womlomo wesibeletho kwakuwukuhlolwa komlomo wesibeletho. 
I-CCTV Finance phambilini yabika ukuthi umuthi wokugoma "nguSirius" wenkampani eyenza imithi yaseBrithani iGlaxoSmithKline-intengo ephikisanayo yezinhlobo ezimbili zamagciwane (i-HPV-16 ne-HPV-18) engadala umdlavuza wesibeletho nomuthi wokugoma onobungozi kakhulu. 
Mayelana nesitatimende sokuthi iminyaka engcono kakhulu yokugoma ineminyaka engu-9 kuya kwengama-25 ubudala, uZhang Youzhong, iphini likamqondisi woMnyango wezezifo zabesifazane kanye ne-Oncology, isibhedlela iQilu saseShandong University, uthe enkulumweni abe nayo neQilu Evening News ukuthi noma esephelile Uneminyaka engama-25 ubudala, uma engazange atheleleke ngegciwane le-HPV, Noma lingathelelekanga ngamagciwane amabili ashiwo ngenhla futhi lisengalijova. China’s annual umdlavuza wesibeletho cases account for more than 28% of the world’s, and it is one of the most common malignant tumors for women. Globally, cervical cancer is also the third most common cancer among women aged 15 to 44. 
Isazi: Kunezimo ezintathu ezingaphezu kweminyaka yobudala engama-25. Ungashayela futhi i-
iwebhusayithi esemthethweni ye-State Food and Drug Administration ukukhombisa ukuthi i-HPV Chinese iyi esibizwa  igciwane le-papilloma lomuntu. Izinhlobo eziningi ze-HPV ezingaphezu kwezingu-100 ezaziwa njengamanje “zinobungozi obuphansi” futhi azihlangene nomdlavuza womlomo wesibeletho, kodwa eziyi-14 zazo zibizwa ngokuthi “ziyingozi enkulu” kanye nezinkinga ezimbili eziyingozi kakhulu (Uhlobo lwe-HPV-16 no-HPV- 18) kungadala cishe i-70% yomdlavuza womlomo wesibeletho. 
Iminyaka efanelekile yokugoma umuthi wokugoma ofanayo “Cirius” kulokhu uneminyaka engu-9 kuya kwengu-25 ubudala. Iningi labasebenzisi be-intanethi asebekhulile baye bazwakalisa ukuzisola. Ngabe abantu abangaphezu kweminyaka engama-25 ubudala bangagonywa? 
Ngo-Agasti 3, uZhang Youzhong, iphini lomqondisi woMnyango we-Gynecologic Oncology eQilu Hospital yaseShandong University, wathi enkulumweni abe nayo neQilu Evening News ukuthi iminyaka engu-9-25 ubudala ingaqondwa njengeminyaka engcono kakhulu yokugoma. Eqinisweni, kunezimo ezintathu lapho lo mgomo usengafakwa khona: owodwa ngukuthi yize ungaphezu kweminyaka engama-25 ubudala, awuthelelekile ngegciwane le-HPV; okunye ukuthi itheleleke ngegciwane le-HPV, kepha ayitheleleki ngezinhlobo ezimbili zegciwane le-HPV, 16, 18; Okwesithathu ukuthi yize i-HPV ithelelekile futhi kuvele izilonda zomdlavuza womlomo wesibeletho, kodwa seyilulamile yaguquka yaba namafu. 
Ngokwemininingwane yomphakathi enikezwe yi-State Food and Drug Administration, ukutheleleka nge-HPV kuvame kakhulu kwabesifazane. Imininingwane ibonisa ukuthi esigabeni esithile empilweni, abesifazane abane kwabangu-4 bazobe bethelelekile. Uma utheleleke nge-HPV enobungozi obukhulu, ingaqhubekela ezingeni eliphakeme lezilonda zomlomo wesibeletho noma ikhule ibe ngumdlavuza womlomo wesibeletho. 
I-HPV idluliswa kakhulu ngokuxhumana ngocansi, futhi ingatheleleka ngokuxhumana okuqondile: isibonelo, ngemuva kokuthinta into ene-HPV esandleni sakho, ungaletha igciwane ezithweni zokuzala ngesikhathi sokuya endlini yangasese noma lapho ugeza; noma uma isitho sokuzala sichayeke ezintweni ze-HPV ezinjengamathawula okugeza zingatheleleka. 
Umuthi wokugomela i-quadrivalent kulindeleke ukuthi ubhalwe ngesikhathi. 
Ngokusho kwe-CCTV Financial Reports, i-cervical general umuthi wokugomela umdlavuza ihlukaniswe ngamanani amabili, amane, nayisishiyagalolunye. Kulokhu igunyaziwe ukuthi idayiswe eMainland. Umuthi wokugoma we-HPV we-GlaxoSmithKline we-bivalent. 
UQiao Youlin, umqondisi weCancer Epidemiology Laboratory yeChinese Academy of Medical Sciences, uthe enkulumweni abe nayo neCCTV News ukuthi ngoMeyi kulo nyaka, umuthi wokugomela i-quadrivalent (osuselwa emuthini wokugoma oyimpumelelo, amagciwane amabili e-HPV abhekiswe, kanye nobudala obusebenzayo uneminyaka engama-20 kuya kwengama-45 ubudala) Sivunyelwe umbuso futhi kulindeleke ukuthi sisohlwini ekupheleni konyaka. 
Maqondana nokuthi umphakathi ungawusebenzisa nini umuthi wokugoma onama-valent ayisishiyagalolunye, u-Qiao Youlin uthe umuthi wokugoma wama-valent ayisishiyagalolunye awukakangeni ezivivinyweni zomtholampilo, futhi isikhathi esilindelwe "side kakhulu." 
Ngabe umuthi wokugoma we-HPV uzofakwa emshuwalense wezokwelapha kungekudala? UZhao Fanghui, iphini likamqondisi, uprofesa kanye nomfundisi ofundisa uMnyango Wezomdlavuza Epidemiology, I-Cancer Hospital, i-Chinese Academy of Medical Sciences, ukholelwa ukuthi akunakwenzeka ukuthi intengo yomuthi wokugoma izokwehliswa ngomncintiswano wezimakethe, bese uzokhokhelwa ngomshuwalense wezokwelapha. 
Mayelana nemithi yokugomela umdlavuza womlomo wesibeletho, i-State Food and Drug Administration ikhumbuze ukuthi njengoba kunamagciwane angaphezu kwengu-10 asengozini enkulu yegciwane le-HPV elihambisana nomdlavuza womlomo wesibeletho, kanti imigomo ibhekiswe kuphela kweminye yayo, noma ngabe igonyiwe, kufanele namanje uhlolwe njalo.

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela Nezinselele
Ukwelashwa kwe-CAR T-Cell

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela kanye Nezinselele

Ukwelashwa kwe-CAR T-cell okusekelwe kumuntu kuguqula ukwelashwa komdlavuza ngokushintsha izakhi zofuzo amaseli omzimba esiguli ukuze aqondise futhi abhubhise amaseli omdlavuza. Ngokusebenzisa amandla esimiso somzimba sokuzivikela ezifweni, lezi zindlela zokwelapha zinikeza ukwelashwa okunamandla futhi okuqondene nomuntu okungahle kube nokuxolelwa okuhlala isikhathi eside ezinhlotsheni ezihlukahlukene zomdlavuza.

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton